Abstract
Dementias were first recognized as a diagnostic issue during the 1800s and have become a major topic only within the last half century. As the population has aged, concern over the dementias has increased because of their higher incidence and the increased sensitivity in medical and mental health circles in recognizing the symptoms of these disorders. Kraepelin (1896) saw dementia as a disease of aging; later versions of his work recognized the writings of Alzheimer (1898) and others who identified the presence of presenile dementias. Over time, there has been increased attention to multiple etiologies and alternative methods of presentation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alafuzoff, I. (1992). The pathology of dementias: An overview. Ada Neurologica Scandinavica, 139 8–15.
Alafuzoff, I., Ronnberg, A., & Asikainen-Gustafsson, S. (1991). Clinical to histopathological correlation of the diagnosis of dementia. International Psychogeriatrics, 3 69–74.
Altman, H., & Normile, H. (1988). What is the nature of the role of the serotonergic nervous system in learning and memory: Prospects for the development of a treatment strategy for senile dementia. Neurobiology of Aging, 9 627–639.
Alzheimer, A. (1898). Neuere Arbeiten uber die Dementia senilis und die auf atherimatoser Gefasserk rankung basierended Gehirnkrankheiten. Monatsschrift fuer Psychiatrie und Neurologie, 3 101–115.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: Author.
Anthony, J., LeResche, L., Niaz, U., von Korff, M., & Folstein, M. (1982). Limits of the mini-mental state as a screening test for dementia and delirium among hospital patients. Psychological Medicine, 12 397–408.
Artola, A., & Singer, W. (1987). Long term potentiation and NMDS receptors in rat visual cortex. Nature, 330 649–652.
Ashford, J. W., Kumar, V., Barringer, M., Becker, M., Bice, J., Ryan, N., & Vicari, S. (1992). Assessing Alzheimer severity with a global clinical scale. International Psychogeriatrics, 1 55–74.
Ball, M. (1980). Features of Creutzfeldt-Jakob disease in brains of patients with familial dementia of the Alzheimer’s type. Canadian Journal of Neurological Sciences, 7 51–57.
Banfi, S., & Dorigotti, L. (1986). Experimental behavioral studies with oxiracetam on different types of chronic cerebral impairment. Clinical Neuropharmacology 9, 519–526.
Beck, E., & Daniel, P. (1987). Neuropathology of transmissible spongiform encephalopathies. In S. Pruisner & M. McKinley (Eds.), Prions: Novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. San Diego: Academic.
Berg, R., Franzen, M., & Wedding, D. (1994). Screening for brain impairment. New York: Springer.
Berman, M. (1990). Severe brain dysfunction: Alcoholic Korsakoff’s syndrome. Alcohol Health and Research, 14 120–129.
Biggins, C. A., Boyd, J., Harrop, F., Madeley, P., Mindham, R., Randall, J., & Spokes, E. (1992). A controlled longitudinal study of dementia in Parkinson’s disease. Journal of Neurology, Neuro-surgery, and Psychiatry, 55 566–571.
Bliwise, D., Carroll, J., Lee, K., Nekich, J., & Dement, W. (1993). Sleep and “sundowning” in nursing home patients with dementia. Psychiatry Research, 48 277–292.
Bliwise, D. L. (1993). Sleep in normal aging and dementia. Sleep, 16 40–81.
Bonte, F. J., Ross, E. D., Chehabi, H. H., & Devous, M. D. (1986). SPECT study of regional cerebral blood flow in Alzheimer’s disease. Journal of Computed Assisted Tomography, 10 579–583.
Bottini, G., Vallar, G., Cappa, S., Monza, G. C., Scarpini, E., Baron, P., Cheldi, A., & Scarlato, G. (1992). Oxiracetam in dementia: A double blind, placebo-controlled study. Ada Neurologica Scandinavica, 86 237–241.
Brandt, J., & Butters, N. (1986). The alcoholic Wernicke-Korsakoff syndrome and its relationship to long term alcohol abuse. In G. Grant & K. Adams (Eds), Neuropsychological assessment of neuropsychiatric disorders. New York: Oxford University Press.
Brenner, R., Ulrich, R., Spiker, D., Sclabassi, R., & Reynolds, C. (1986). Computerized EEG spectral analysis in elderly normal, demented, and depressed subjects. Eledroencephalography and Clinical Neurophysiology, 64 483–492.
Breslau, J., Starr, A., Sicotte, N., Higa, J., & Buchsbaum, M. (1989). Topographic EEG changes with normal aging and SDAT. Eledroencephalography and Clinical Neurophysiology, 40 281–289.
Brown, P. (1989). Central nervous system amyloidoses: A comparison of Alzheimer’s disease and Creutzfeldt-Jakob disease. Neurology, 39 1103–1105.
Burns, A., Philpot, M. P., Costa, D. C., Ell, P. J., & Levy, R. (1989). The investigation of Alzheimer’s disease with single photon emission tomography. Journal of Neurology, Neurosurgery and Psychiatry, 52 248–253.
Carlyle, W., Ancill, R., & Sheldon, L. (1993). Aggression in the demented patient: A double blind study of loxapine versus haloperidol. International Clinical Psychopharmacology, 8 103–108.
Chanarin, I., Deacon, R., Lumb, M., & Perry, J. (1989). Cobalaminfolate interrelationships. Blood Review, 3 211–215.
Copeland, J., Kelleher, N., Kellett, J., Gourlay, A., & Gurland, B. (1976). A semistructured clinical interview for the assessment of diagnosis and mental state in the elderly. Psychological Medicine, 6 439–449.
Copeland, J. R., Dewey, N., Henderson, A., Kay, D., & Neal, C. (1988). The Geriatric Mental State (GMS) used in the community: Replication studies of the computerized diagnoses AGECAT. Psych ological Medicine, 18 219–223.
Corey-Bloom, J., Galasko, D., Hofstetter, R., Jackson, J., & Thal, L. (1993). Clinical features distinguishing large cohorts with possible AD., probable AD., and mixed dementia. Journal of the American Geriatrics Society, 41 31–37.
Cummings, J., & Benson, D. (1992). Dementia. Toronto: Butterwirth-Heinemann.
Cutler, N. R., Fakouhi, D., Smith, W. T., Hendrie, H. C., Matsuo, F., Sramek, J. J., & Herting, R. L. (1993). Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer’s type. Journal of Geriatric Psychiatry and Neurology, 6 115–119.
DeCarli, C., Haxby, J., Gillette, J., Teichberg, D., Rapoport, S., & Schapiro, M. (1992). Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology, 42 2029–2036.
Eberling, J. L., Jagust, W. J., Reed, B. R., & Baker, M. G. (1992). Reduced temporal lobe blood flow in Alzheimer’s disease. Neurobiology of Aging, 13 483–491.
Edwards, A. J. (1993). Dementia. New York: Plenum Press.
Evenhuis, H. M. (1992). Evaluation of a screening instrument for dementia in aging mentally retarded persons. Journal of Intellectual Disability Research, 36 337–347.
Fields, S., Fulop, G., Sachs, C., Strain, J., & Fillit, H. (1992). Usefulness of the neurobehavioral cognitive status examination in the hospitalized elderly. International Psychogeriatrics, 4 93–102.
Fischhof, P., Saletu, B., Ruther, E., Litschauer, G., Moslinger-Gehmayr, R., & Herrmann, W. (1992). Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID). Neuropsychobiology, 26 65–70.
Folstein, M., Folstein, S., & McHugh, P. (1975). “Mini-mental state”: A practical method for grading the cognitive states of patients for the clinician. Journal of Psychiatric Research, 12 189–198.
Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., & Winblad, B. (1992). Clinical diagnosis of Alzheimer’s disease and other dementias in a population survey. Archives of Neurology, 49 927–932.
Galasko, D., Klauber, M., Hofstetter, R., Salmon, D., Lasker, B., & Thal, L. (1990). The MMSE in the early diagnosis of Alzheimer’s disease. Archives of Neurology, 47 49–52.
Giurgea, C. (1972). Vers une pharmacologie de l’activité integrative du cerveau: Tentative du concept nootrope en psychopharmacologie. Actual Pharmacology, 25 115–156.
Golden, C., Osmon, D., Moses, J., & Berg, R. (1981). Interpretation of the Halstead-Reitan Neuropsychological Battery. New York: Harcourt Brace Jovanovich.
Golden, C., Zillmer, E., & Spiers, M. (1992). Neuropsychological assessment and intervention. Springfield, IL: Thomas.
Goodwin, J. S., Goodwin, J. M., & Garry, P. J. (1983). Association between nutritional status and cognitive functioning in a healthy elderly population. Journal of the American Medical Association, 249 2917–2921.
Gottfries, C. (1991). Classifying organic mental disorders and dementia—A review of historical perspectives. International Psychogeriatrics, 3 9–17.
Gottfries, C., Adolfsson, R., & Aquilonius, S. (1983). Biochemical changes in dementia disorders of the Alzheimer type (AD/SDAT). Neurobiology of Aging, 4 261–271.
Günther, W., Giunta, R., Klages, U., Haag, C., Steinberg, R., Satzger, W., Jonitz, L., & Engel, R. (1993). Findings of electroencephalographic brain mapping in mild to moderate dementia of the Alzheimer type during resting, motor, and music-perception conditions. Psychiatry Research: Neuroimaging, 50 163–176.
Gurland, B., Kuriansky, J., Sharpe, L., Simon, R., & Stiller, P. (1977). The comprehensive assessment and referral evaluation (CARE). International Journal of Aging and Human Development, 8 9–42.
Gustafson, L. (1992). Clinical classification of dementia conditions. Acta Neurologica Scandinav-ica, 139 16–20.
Herrmann, W., & Stephan, K. (1992). Moving from the question of efficacy to the question of therapeutic relevance: An exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. International Psychogeriatrics, 4 25–44.
Holttum, J., & Gershon, S. (1992). The cholinergic model of dementia, Alzheimer type: Progression from the unitary transmitter concept. Dementia, 3 174–185.
Israel, J., Kozarevic, N., & Sarorius, N. (1984). Source book of geriatric assessment. Basel, Switzerland: Karger.
Jacobson, R., Acker, C., & Lishman, W. (1990). Patterns of neuropsychological deficit in alcoholic Korsakoff’s syndrome. Psychological Medicines, 20 321–334.
Jarvik, L. F. (1992). Possible biological basis for a major memory disorder. In J. Morley, R. Coe, R. Strong, & G. Grossbergs (Eds.), Memory function and age related disorders. New York: Springer.
Johnson, J. W., & Asher, P. (1987). Gylcine potentiates the NMDS response in cultured mouse brain neurons. Nature, 325 31–35.
Jones, H., Hedley-White, T., & Friedberg, S. (1985). Ataxic Creutzfeldt-Jakob disease: Diagnostic techniques and neuropathological observations in early disease. Neurology, 35 254–357.
Jung, R., & Solomon, K. (1993). Clinical practice and psychiatric manifestations of Pick’s disease. International Psychogeriatrics, 5 187–202.
Kay, D., Henderson, A., Scott, R., Wilson, J., Rickwood, D., & Grayson, D. (1985). Depression and dementia among the elderly living in the Hobart community. Psychological Medicine, 15 771–788.
Kraepelin, E. (1896). Psychiatrie: Ein Lehrbuch für Studierende und Aerzte. Leipzig, Germany: Verlag von Johann Ambrosius Bath.
Kuhn, F. J., Schingnitz, G., Lehr, E., Montagna, E., Hansen, H. D., & Giachetti, A. (1988). Pharmacology of WEB-1881-F, a central cholinergic agent, which enhances cognition and cerebral metabolism. Archives of Internal Pharmacodynamic Therapy, 292 13–34.
Kumar, A., Schapiro, M. B., Grady, C., Haxby, J. V., Wagner, E., Salerno, J. A., Friedland, R. P., & Rapoport, S. (1991). High-resolution PET studies in Alzheimer’s disease. Neuropsychophar-macology, 4 35–46.
Kurz, A., Haupt, M., Pollmann, S., & Romero, B. (1992). Alzheimer’s disease: Is there evidence of phenomenological subtypes? Observations from a longitudinal study. Dementia, 3 320–327.
Lamberty, G. J., & Bieliauskas, L. A. (1993). Distinguishing between depression and dementia in the elderly: A review of neuropsychological findings. Archives of Clinical Neuropsychology, 8 149–170.
Levitt, A. J., & Karlinsky, H. (1992). Folate, vitamin B12, and cognitive impairment in patients with Alzheimer’s disease. Acta Psychiatrica Scandinavica, 86 301–305.
Marsden, C., & Fahn, S. (1987). Movement disorders II. London: Butterworths.
Mendez, M., Selwood, A., Mastri, A., & Frey, W. (1993). Pick’s disease versus Alzheimer’s disease: A comparison of clinical characteristics. Neurology, 43 289–292.
Mielke, R., Herholz, K., Grond, M., Kessler, J., & Heiss, W. (1992). Severity of vascular dementia is related to volume of metabolically impaired tissue. Archives of Neurology, 49 909–913.
Miller, B., Cummings, J., Villanueva-Meyer, J., Boone, K., Mehringer, C., Lesser, I., & Mena, I. (1991). Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics. Neurology 41, 1374–1382.
Miyauchi, T., Hagimoto, H., Ishii, M., Endo, S., Tanaka, K., Kajiwara, S., Endo, M., Kajiwara, A., & Kosaka, K. (1994). Quantitative EEG in patients with presenile dementia of the Alzheimer type. Ada Neurologica Scandinavica, 89 56–64.
Mondadori, C., & Classen, W. (1984). Effect of oxiracetam on the performance of aged rates in a one way active avoidance situation. Clinical Neuropharmacology, 1984 770–771.
Nissen, T., Mellgren, S., & Selseth, B. (1989). Démens evaluert med MMSE. Tidsskrift for den Norske Laegeforening, 109 1158–1162.
Oberholzer, A., Hendriksen, C., Monsch, A., Hieierli, B., & Stahelin, H. (1992). Safety and effectiveness of low-dose clozapine in psychogeriatric patients: A preliminary study. International Psychogeriatrics, 4 187–195.
Ohno, M., Yamamoto, T., Kitajima, I., & Ueki, S. (1990). WEB 1881 F ameliorates impairment of working memory induced by scopolamine and cerebral ischemia in the three panel runway task. Japanese Journal of Pharmacology, 54 53–60.
Olafsson, K., Jorgensen, S., Jensen, H., Bille, A., Amp, P., & Andersen, J. (1992). Fluvoxamine in the treatment of demented patients: A double blind, placebo controlled study. Acta Psychiatrica Scandinavica, 85 453–456.
Onofri, M., Gambi, D., Del Re, M., Fulgente, T., Bazzano, S., Colamartino, P., & Malatesta, G. (1991). Mapping of event related potentials to auditory and visual odd ball paradigms in patients affected by different forms of dementia. European Neurology, 31 259–269.
Overall, J. E., & Schaltenbrand, R. (1992). The SKT neuropsychological test battery. Journal of Geriatric Psychiatry and Neurology, 5 220–227.
Parsons, O., & Nixon, S. (1993). Neurobehavioral sequelae of alcoholism. Neurologic Clinics, 11 205–218.
Pinner, E., & Rich, C. (1988). Effects of trazodone on aggressive behavior in seven patients with organic mental disorder. American Journal of Psychiatry, 145 1295–1296.
Powell, A. L., Mezrich, R. S., Coyne, A. C., Loesberg, A., & Keller, I. (1993). Convex third ventricle: A possible sign for dementia using MRI. Journal of Geriatric Psychiatry and Neurology, 217-221.
Rapp, M. S., Flint, A., Herrmann, N., & Proulx, G. (1992). Behavioral disturbances in the demented elderly: Phenomenology, pharmacotherapy, and behavioural management. Canadian Journal of Psychiatry, 37 651–657.
Roman, G., Tatemichi, T., Erkinguntti, T., Cummings, J., Masdeu, J., Garcia, J., Amaducci, L., Orgogozo, J., Brun, A., Hofman, A., Moody, D., O’Brien, M., Yamaguchi, T., Grafman, J., Drayer, B., Bennet, D., Fisher, M., Ogata, J., Kokmen, E., Bermejo, E., Wolf, P., Gorelick, P., Bick, K., Pageau, A., Bell, M., DeCarli, C., Culebras, A., Korczyn, Z., Bogousslavsky, J., Hartmann, A., & Scheinberg, P. (1993). Vascular dementia: Diagnostic criteria for research studies. Neurology, 43 250–260.
Rosen, J., Mulsant, B., & Wright, B. (1992). Agitation in severely demented patients. Annals of Clinical Psychiatry, 4 207–215.
Roth, M., Tym, E., Mountjoy, C., Huppert, F., & Hendrie, H. (1986). CAMDE: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149 698–709.
Sabe, L., Jason, L., Juejati, M., Leiguarda, R., & Starkstein, S. (1993). Sensitivity and specificity of the mini-mental state exam in the diagnosis of dementia. Behavioural Neurology, 6 207–210.
Saletu, B., & Anderer, P. (1988). EEG Mapping in der psychiatrischen diagnose und thera-pieforschung. In B. Saletu (Ed.), Biologische Psychiatrie. New York: Springer-Verlag.
Saletu, B., Anderer, P., Fischhof, P., Lorenz, H., Barousch, R., & Bohmer, F. (1992). EEG mapping and psychopharmacological studies with deribufylline in SDAT and MID. Biological Psychiatry, 32 668–681.
Sawada, H., Udaka, F., Kameyama, M., Seriu, N., Nishinaka, K., Shindou, K., Kodama, M., Nishitani, N., & Okumiya, K. (1992). SPECT findings in Parkinson’s disease associated with dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 55 960–963.
Schneider, L., & Sobin, P. (1992). Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer’s disease and other dementias. Psychopharmacology Bulletin, 28 71–79.
Schneider, L., Pollock, V., & Lyness, S. (1990). A metaanalysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatric Association, 38 553–563.
Shorvon, S. D., Carney, M. W. P., Chanarin, I., & Reynolds, E. H. (1980). The neuropsychiatry of megaloblastic anaemia. British Journal of Medicine, 281 1036–1038.
Shulman, R. (1967). Vitamin B12 deficiency and psychiatric illness. British Journal of Psychiatry, 113 252–256.
Simpson, S., & Foster, D. (1986). Improvement in organically disturbed behavior with trazodone treatment. Journal of Clinical Psychiatry, 47 191–193.
Skoog, I., Nilsson, L., Palmertz, B., Andreasson, L., & Svanborg, A. (1993). A population based study of dementia in 85 year olds. New England Journal of Medicine, 328 153–158.
Sneath, P., Chanarin, I., Hodkinson, H. M., McPherson, C. K., & Reynolds, E. H. (1973). Folate status in a geriatric population and its relation to dementia. Age and Aging, 2 177–182.
Spignoli, G., Pedata, F., Giovanelli, L., Banfi, S., Moroni, F., & Pepeu, G. (1986). Effect of oxiracetam and piracetam on central cholinergic mechanisms and active avoidance acquisition. Clinical Neuropharmacology, 9 S39–S47.
Strathmann, G. C. (1988). Possible neurotransmitter basis of behavioral changes in Alzheimer’s disease. Annals of Neurology, 23 616–620.
Swaab, D. F. (1991). Brain aging and Alzheimer’s disease, “wear and tear” versus “use it or lose it.” Neurobiology of Aging, 12 317–324.
Urakami, K., Shimomura, T., Ohshima, T., Okada, A., Adachi, Y., Takahashi, K., Asakura, M., & Matsumura, R. (1993). Clinical effect of WEB 1881 (Nebracetam Fumurate) on patients with dementia of the Alzheimer type and study of its clinical pharmacology. Clinical Neuro-phamacology, 16 347–358.
Van der Cammen, T., Van Harskamp, F., Stronks, D., Passchier, J., & Schudel, W. (1992). Value of the mini-mental status examination and informants’ data for the detection of dementia in geriatric outpatients. Psychological Reports, 71 1003–1009.
Zappoli, R., Ametoli, G., Paganini, M., Battaglia, A., Novellini, R., & Pamparana, F. (1991). Topographic bit-mapped event-related neurocognitive potentials and clinical status in patients with primary presenile mental decline chronically treated with nicergoline. Current Therapeutic Research, 49 1078–1097.
Zaudig, M. (1992). A new systematic method of measurement and diagnosis of “mild cognitive impairment” and dementia according to ICD-10 and DSM-III-R criteria. International Psy-chogeriatrics, 4 203–239.
Zaudig, M., Mittelhammer, J., Hiller, W., Pauls, A., & Thora, C. (1991). SIDAM-A structured interview for the diagnosis of dementia of the Alzheimer type multi-infarct dementia, and dementias of other etiology according to ICD-10 and DSM-III-R. Psychological Medicine, 21 225–236.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Golden, C.J., Chronopolous, A. (1998). Dementia. In: Hersen, M., Van Hasselt, V.B. (eds) Handbook of Clinical Geropsychology. The Springer Series in Adult Development and Aging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0130-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0130-9_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0132-3
Online ISBN: 978-1-4899-0130-9
eBook Packages: Springer Book Archive